MoneyWorks4Me

The sales figure stood at Rs. 2292.00 millions for the March 2026 quarter. The mentioned figure indicates a growth of about 32.79% as compared to Rs. 1726.00 millions during the year-ago period.A good growth in profit of 35.60% reported to Rs. 678.00  millions over Rs. 500.00 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 944.00 millions from 692.00 millions in the quarter ended March 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202512 202412 % Var
Sales 2292.00 1726.00 32.79 2292.00 1726.00 32.79 8784.00 7245.00 21.24
Other Income 56.00 52.00 7.69 56.00 52.00 7.69 184.00 130.00 41.54
PBIDT 944.00 692.00 36.42 944.00 692.00 36.42 3274.00 2836.00 15.44
Interest 5.00 4.00 25.00 5.00 4.00 25.00 20.00 39.00 -48.72
PBDT 939.00 688.00 36.48 939.00 688.00 36.48 3320.00 2513.00 32.11
Depreciation 32.00 20.00 60.00 32.00 20.00 60.00 117.00 45.00 160.00
PBT 907.00 668.00 35.78 907.00 668.00 35.78 3203.00 2468.00 29.78
TAX 229.00 168.00 36.31 229.00 168.00 36.31 802.00 658.00 21.88
Deferred Tax -12.00 -2.00 500.00 -12.00 -2.00 500.00 -18.00 -38.00 -52.63
PAT 678.00 500.00 35.60 678.00 500.00 35.60 2401.00 1810.00 32.65
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 41.19 40.09 2.73 41.19 40.09 2.73 37.27 39.14 -4.78
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..